Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 9138

With its growing aging population, Singapore has a looming crisis, but could also be primed to become a major player in the rejuvenation biotechnology industry.

Singapore has one of the fastest-aging populations in the world. Senior citizens 65 years old or older are expected to make up almost half of Singapore’s population by 2050. Unfortunately, this swelling population is spending more time living with sickness, even though they live longer. While average lifespans have been extended, healthspans have not. [1] Singaporeans have an impressive average life expectancy of 84.8 years, but an average Singaporean born in 2017 is predicted to spend the last ten and a half years in sickness, compared to how a Singaporean born in 1999 is likely to spend only nine twilight years in deteriorating health.

This is becoming a massive concern for the Singaporean government because of the financial strain that this is imposing on Singapore’s budget. Having the world’s second-lowest birth rate coupled with a rapidly aging population means that the ratio of working adults to senior citizens is quickly shrinking. In 2007, there were 6.9 working adults for every senior citizen. By 2030, there will be 2.3 working adults per senior citizen.

In under a decade, Singapore’s healthcare budget more than doubled from S$4 billion in 2010 to S$10 billion in 2017. [2] Among the developed nations of the world, Singapore has a reputation for being one of the most fiscally conservative; there’s a socio-political stigma against the term “welfare state” in Singapore. Since its unprecedented independence in 1965, Singapore has had a general zeitgeist of “every man for himself,” as we are a nation with no natural resources. Our highly-educated workforce, along with our strategic geographical location, is the primary resource undergirding our knowledge-based economy.

Continue reading “The Rejuvenation Market in Singapore” | >

Pichugin2006_Fahy2012_FrontPageImagesRotated

21st Century Medicine (21CM) is a cryobiology research company whose core mission is to develop a cryopreservation protocol sufficiently benign that whole, donated human organs could be vitrified (stored below −130 degrees Celsius without ice formation) and rewarmed when needed for transplantation –an incredibly ambitious goal that has so far eluded medical researchers. 21CM’s scientists are the original pioneers of whole organ vitrification and have been diligently working on the technique for decades. A significant milestone of their progress toward that goal is their demonstration work on rabbit kidneys. Two of their most relevant publications are “Cryopreservation of organs by vitrification: perspectives and recent advances” (Fahy, Wowk, Wu, Phan, Rasch, Chang & Zendejas 2004) and “Physical and biological aspects of renal vitrification” (Fahy, Wowk, Pagotan, Chang, Phan, Thomson & Phan 2009). These papers are a fantastic resource for anyone interested in just how difficult it is to cryopreserve large organs (and by extension whole animals) for long-term storage with the intent on later recovery of biological function. In short, it is incredibly difficult but progress is slowly being made.

The state-of-the-art whole organ vitrification techniques developed by 21CM are the basis of the human cryopreservation protocols used by some cryonics companies (e.g. Alcor). This is made clear in Alcor’s 2004 publication in the New York Academy of Sciences “The Arrest of Biological Time as a Bridge to Engineered Negligible Senescence” (Lemler, Harris, Platt & Huffman 2004).

21CM has been an official competitor in our Brain Preservation Prize competition since 2012. They actually have two separate preservation techniques competing for our prize: the “straight” cryopreservation\cryonics technique described on this page, and a radically new technique called “Aldehyde Stabilized Cryopreservation” (ASC), described on a separate page,which they developed to overcome the “tissue shrinkage” issues described on this page and to optimize ultrastructure preservation at the expense of viability.

Read more | >

Circa 2011

Scientists have found a gene that can ‘lock’ and ‘unlock’ certain sections of your genetic code, allowing other genes to be expressed in your body. If you are under enough stress, this gene springs into action.

So you think you have access to all your DNA just by being born? Think again. You have to earn it, people. You have to work to get there. You have to suffer. Epigeneticists have proved this to be so, but they also might have a cheat code.

Read more | >

Oil spill cleanup technology is a surprisingly innovative field—we learned as much in the wake of the BP Gulf disaster, when everyone from conservation biologists to barbers to Kevin Costner rushed to sell the government on their wild, sometimes literally hairy oil-sucking solutions. We had rubber goop that turned oil solid, massive bags of hair, and MIT’s previous entry into the cleanup fray, robotic oil-eating submarines.

But now the renowned science lab has a better idea: nano-magnets.

MIT researchers have developed a new technique for magnetically separating oil and water that could be used to clean up oil spills. They believe that, with their technique, the oil could be recovered for use, offsetting much of the cost of cleanup.

Read more | >

It’s a familiar problem: open-source software is widely acknowledged as crucially important in science, yet it is funded non-sustainably. Support work is often handled ad hoc by overworked graduate students and postdocs, and can lead to burnout. “It’s sort of the difference between having insurance and having a GoFundMe when their grandma goes to the hospital,” says Anne Carpenter, a computational biologist at the Broad Institute of Harvard and MIT in Cambridge, Massachusetts, whose lab developed the image-analysis tool CellProfiler. “It’s just not a nice way to live.”

Releasing lab-built open-source software often involves a mountain of unforeseen work for the developers.

Read more | >

A new project announced last week will start helping close the gap, though. The New Jersey Board of Public Utilities (NJBPU) chose Ørsted of Denmark to build a 1.1 gigawatt wind farm off the coast of Atlantic City. Dubbed (somewhat un-originally) Ocean Wind, the farm will be the biggest of its kind in the US and is estimated to be done by 2024. For comparison, the only wind farm currently operating in the US, off the coast of Rhode Island, has a paltry 30-megawatt production capacity.

Ocean Wind’s 1.1 gigawatts of energy will be enough to power about 500,000 homes. The project is slated to create 15,000 new jobs and generate up to $1.2 billion in additional economic benefits.

As of May of this year, there were 15 proposals in the works for new offshore wind farms along the US east coast (and that doesn’t include projects in California, Hawaii, South Carolina, and New York).

Read more | >